miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1

Conclusion: MiR-1290 may act as an oncogene by directly targeting the 3 ’-untranslated region of IKK1, and the miR-1290/IKK1 pathway may prove to be a novel diagnostic and therapeutic target for PDAC.Cell Physiol Biochem 2018;51:711 –728
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research